Transcode Therapeutics, Inc.

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Ticker: RNAZ
CIK: 0001829635
Exchange: Nasdaq
Universe updated: 2026-08-22

Open SEC filings

Market price

Latest quoteOpens Google

TickerGrove coverage

Latest on Transcode Therapeutics, Inc.

Companies

TransCode CFO Fitzgerald resigns; separation pact provides up to $1.25 million

The departure took effect September 9. Funding thresholds govern payment timing and option acceleration, while John Tattory takes over as interim CFO through Stout.

Published 09-12-2026 · Event 09-09-2026 · TransCode Therapeutics, Inc. Form 8-K — EDGAR index

Research foundation

Read the filing with the right frame

Company analysis

Revenue, EPS and guidance answer different earnings questions

Revenue is the top-line amount recognized from a company’s activities under its accounting policy.

Earnings reading room →

Company analysis

The three financial statements describe one business from different angles

The income statement records revenue and expenses over a period.

Company research desk →

Investing basics

Stocks, ETFs and indexes are different objects

A stock is an ownership interest in one company.

Company research desk →